Hypercalcemia epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(4 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hypercalcemia}} | {{Hypercalcemia}} | ||
{{CMG}}; {{AE}}{{Anmol}} | |||
==Overview== | |||
The prevalence of hypercalcemia in the cancer patient is approximately 3286.23 per 100,000 individuals over the period of 2009 to 2013 in the United States. | |||
==Epidemiology and Demographics== | |||
Primary hyperparathyroidism is the most common cause of hypercalcemia. For epidemiology and demographics of hyperparathyroidism, [[Hyperparathyroidism epidemiology and demographics|click here]]. | |||
===Prevalence=== | |||
* The prevalence of hypercalcemia in the cancer patient is approximately 3286.23 per 100,000 individuals over the period of 2009 to 2013 in the United States.<ref name="pmid27263488">{{cite journal| author=Gastanaga VM, Schwartzberg LS, Jain RK, Pirolli M, Quach D, Quigley JM et al.| title=Prevalence of hypercalcemia among cancer patients in the United States. | journal=Cancer Med | year= 2016 | volume= 5 | issue= 8 | pages= 2091-100 | pmid=27263488 | doi=10.1002/cam4.749 | pmc=4899051 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27263488 }} </ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Endocrinology]] | |||
[[Category:Needs content]] | [[Category:Needs content]] | ||
{{WS}} | |||
{{WH}} |
Latest revision as of 20:31, 5 July 2018
Hypercalcemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hypercalcemia On the Web |
American Roentgen Ray Society Images of Hypercalcemia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
The prevalence of hypercalcemia in the cancer patient is approximately 3286.23 per 100,000 individuals over the period of 2009 to 2013 in the United States.
Epidemiology and Demographics
Primary hyperparathyroidism is the most common cause of hypercalcemia. For epidemiology and demographics of hyperparathyroidism, click here.
Prevalence
- The prevalence of hypercalcemia in the cancer patient is approximately 3286.23 per 100,000 individuals over the period of 2009 to 2013 in the United States.[1]
References
- ↑ Gastanaga VM, Schwartzberg LS, Jain RK, Pirolli M, Quach D, Quigley JM; et al. (2016). "Prevalence of hypercalcemia among cancer patients in the United States". Cancer Med. 5 (8): 2091–100. doi:10.1002/cam4.749. PMC 4899051. PMID 27263488.